Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Morgan

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Current Neurology and Neuroscience Reports|July 2, 2008
Neuroimaging and transcranial ultrasonography in Parkinson's diseaseShyamal H Mehta, John C Morgan, Kapil D Sethi
Clinical & Experimental Metastasis|August 9, 2005
Distinct and opposite roles for SH2 and SH3 domains of v-src in embryo survival and hemangiosarcoma formationJohn C Morgan, John E Majors, Deni S Galileo
Neuropsychiatric Disease and Treatment|March 21, 2009
Rivastigmine for the treatment of dementia associated with Parkinson's diseaseJennifer L Reingold, John C Morgan, Kapil D Sethi
Current Treatment Options in Neurology|April 15, 2009
Paroxysmal dyskinesiasShyamal H Mehta, John C Morgan, Kapil D Sethi
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 10, 2021
Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouseYutaka Itokazu, Takahiro Fuchigami, John C Morgan, et al.
Neuroscience and Biobehavioral Reviews|July 17, 2017
Cognitive workload across the spectrum of cognitive impairments: A systematic review of physiological measuresMaud Ranchet, John C Morgan, Abiodun E Akinwuntan, et al.
Molecular Neurobiology|February 28, 2023
Restoration of Adult Neurogenesis by Intranasal Administration of Gangliosides GD3 and GM1 in The Olfactory Bulb of A53T Alpha-Synuclein-Expressing Parkinson's-Disease Model MiceTakahiro Fuchigami, Yutaka Itokazu, John C Morgan, et al.
Nature Clinical Practice. Neurology|September 7, 2007
A case of levodopa-responsive camptocormia associated with advanced Parkinson's diseaseBryan Ho, Rajan Prakash, John C Morgan, et al.
Parkinson'S Disease|November 15, 2018
Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson's Disease with Motor FluctuationsJohn C Morgan, Rohit Dhall, Robert Rubens, et al.
Neurology|September 28, 2005
Psychogenic paroxysmal dyskinesia following paroxysmal hemidystonia in multiple sclerosisJohn C Morgan, Mary Hughes, Ramon E Figueroa, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Current Neurology and Neuroscience Reports|July 2, 2008
Neuroimaging and transcranial ultrasonography in Parkinson's diseaseShyamal H Mehta, John C Morgan, Kapil D Sethi
Clinical & Experimental Metastasis|August 9, 2005
Distinct and opposite roles for SH2 and SH3 domains of v-src in embryo survival and hemangiosarcoma formationJohn C Morgan, John E Majors, Deni S Galileo
Neuropsychiatric Disease and Treatment|March 21, 2009
Rivastigmine for the treatment of dementia associated with Parkinson's diseaseJennifer L Reingold, John C Morgan, Kapil D Sethi
Current Treatment Options in Neurology|April 15, 2009
Paroxysmal dyskinesiasShyamal H Mehta, John C Morgan, Kapil D Sethi
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 10, 2021
Intranasal infusion of GD3 and GM1 gangliosides downregulates alpha-synuclein and controls tyrosine hydroxylase gene in a PD model mouseYutaka Itokazu, Takahiro Fuchigami, John C Morgan, et al.
Neuroscience and Biobehavioral Reviews|July 17, 2017
Cognitive workload across the spectrum of cognitive impairments: A systematic review of physiological measuresMaud Ranchet, John C Morgan, Abiodun E Akinwuntan, et al.
Molecular Neurobiology|February 28, 2023
Restoration of Adult Neurogenesis by Intranasal Administration of Gangliosides GD3 and GM1 in The Olfactory Bulb of A53T Alpha-Synuclein-Expressing Parkinson's-Disease Model MiceTakahiro Fuchigami, Yutaka Itokazu, John C Morgan, et al.
Nature Clinical Practice. Neurology|September 7, 2007
A case of levodopa-responsive camptocormia associated with advanced Parkinson's diseaseBryan Ho, Rajan Prakash, John C Morgan, et al.
Parkinson'S Disease|November 15, 2018
Dosing Patterns during Conversion to IPX066, Extended-Release Carbidopa-Levodopa (ER CD-LD), in Parkinson's Disease with Motor FluctuationsJohn C Morgan, Rohit Dhall, Robert Rubens, et al.
Neurology|September 28, 2005
Psychogenic paroxysmal dyskinesia following paroxysmal hemidystonia in multiple sclerosisJohn C Morgan, Mary Hughes, Ramon E Figueroa, et al.
Pageof 12